A cell model for discovering biomarkers and druggable targets for pulmonary fibrosis May 1, 2023 - Jan 31, 2025
Projects (158)
Effect of hypoxia on prostacyclin-mediated inhibition of platelet function Jan 1, 2023 - Dec 31, 2025
Tissue hypoxia occurs in multiple cardiovascular and pulmonary conditions that have platelet activation or hyperreactivity, including myocardial infarction, stroke, chronic obstructive pulmonary disease (COPD) and sleep apnoea. However, knowledge on...
Read More about Effect of hypoxia on prostacyclin-mediated inhibition of platelet function.
Radiopharmacy GMP radiotracer production Feb 1, 2023 - Dec 31, 2023
Using a custom-designed spheroid-on chip model to study impact of sheer stress under low oxygen conditions Jul 1, 2022 - Dec 31, 2022
Metastatic, or secondary, cancer has particularly poor prognosis, accounting for up to 90% of all cancer deaths. Therefore, identification and validation of early metastasis biomarkers and/or defining metastasis-specific therapeutic targets is essent...
Read More about Using a custom-designed spheroid-on chip model to study impact of sheer stress under low oxygen conditions.
Quantitative proteomic analysis of pancreatic cyst fluid for early detection of cancer using University of Hull HPC Viper Apr 1, 2022 - Feb 28, 2023
The timely diagnosis of pancreatic ductal adenocarcinoma (PDAC) is challenging due to a lack of disease-specific symptoms, resulting in the majority of patients presenting with advanced disease and poor prognosis. Detection of PDAC, ideally at a prem...
Read More about Quantitative proteomic analysis of pancreatic cyst fluid for early detection of cancer using University of Hull HPC Viper.
Fully humanized model to study the role of endothelial cells in ageing human lung Jun 6, 2022 - Aug 26, 2022
PreclinHUPET2: Enabling Enhanced Preclinical Nuclear Imaging For The North Of England Feb 1, 2023 - Jan 31, 2024
The grant application is to upgrade the preclinical scanning facilities for nuclear imaging of small animals (mice and rats) at the University of Hull. These facilities are used for research into disease and human health. The main areas that will be...
Read More about PreclinHUPET2: Enabling Enhanced Preclinical Nuclear Imaging For The North Of England.
A novel, first-in-its-kind, aptamer-based LYTACs to address the unmet clinical need of diabetic wounds. Dec 1, 2022 - Nov 30, 2027
Microplastics: Exploring the Role of Microplastics in Lung Disease. Jan 1, 2023 - Dec 31, 2023
Equipment - orbital shaker Aug 1, 2022 - Jul 31, 2023
Endometriosis affects 1 in 10 women worldwide, the same frequency as diabetes but it has had a tiny amount of research funding in comparison. Endometriosis causes debilitating pain that can lead to loss of work, impact mental health and is a major ca...
Read More about Equipment - orbital shaker.
TARGETING THE MYOSIN LIGHT CHAIN PHOSPHATASE WITH PEPTIDE DISRUPTORS: A NOVEL ANTIPLATELET THERAPEUTIC APPROACH Jul 3, 2023 - Jul 2, 2026
Platelet activation and thrombus formation play key roles in the pathogenesis of ischaemic cardiovascular diseases, one of the major causes of death in the UK. Many antiplatelet agents have been developed to manage these conditions; however, they are...
Read More about TARGETING THE MYOSIN LIGHT CHAIN PHOSPHATASE WITH PEPTIDE DISRUPTORS: A NOVEL ANTIPLATELET THERAPEUTIC APPROACH.
Study of the lung endothelium in idiopathic pulmonary fibrosis Sep 1, 2020 - Sep 30, 2023
First-in-man clinical trial investigating the effect of hair cycle modulation on wound healing Mar 1, 2023 - Jan 31, 2025
Background: Chronic wounds, delayed healing and surgical site infection affect a significant number of patients and come at great cost to healthcare providers. They substantially decrease quality of life and may lead to repeated hospital admission, s...
Read More about First-in-man clinical trial investigating the effect of hair cycle modulation on wound healing.
Support for the Thyroid Cancer Research team Oct 1, 2022 - Jul 31, 2024
Support for the Thyroid Cancer Research team.
ACF 2023-2026 Sep 1, 2023 - Aug 31, 2026